ArticleInfection2026

Clinical and health economic impact of isavuconazole for treatment of invasive aspergillosis and mucormycosis: a retrospective, matched multicentre cohort study in Germany.

Marie Engelhard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.